363 related articles for article (PubMed ID: 8513428)
1. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors.
Juggi JS; Koenig-Berard E; Van Gilst WH
Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectives.
Schölkens BA; Linz W
Clin Physiol Biochem; 1990; 8 Suppl 1():33-43. PubMed ID: 2147878
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
4. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Borghi C; Cosentino E; De Sanctis D
Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. [Action of converting enzyme inhibitors on myocardial ischemia and reperfusion injuries].
Galinier M; Bounhoure JP
Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():99-104. PubMed ID: 8304819
[TBL] [Abstract][Full Text] [Related]
7. [Prevention with angiotensin-converting enzyme (ACE) inhibitors].
Ertl G; Gaudron P; Neubauer S; Bauer B
Z Kardiol; 1992; 81 Suppl 4():205-10. PubMed ID: 1290300
[TBL] [Abstract][Full Text] [Related]
8. Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction.
Dai W; Kloner RA
Postgrad Med; 2011 Mar; 123(2):49-55. PubMed ID: 21474893
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hypertensive heart disease with ACE inhibitors.
Stumpe KO
J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S166-71. PubMed ID: 2485024
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
[TBL] [Abstract][Full Text] [Related]
11. Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts.
Anderson B; Khaper N; Dhalla AK; Singal PK
Can J Cardiol; 1996 Oct; 12(10):1099-104. PubMed ID: 9191504
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
Tokmakova M; Solomon SD
Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
[TBL] [Abstract][Full Text] [Related]
13. Effect of ACE inhibition on neurohormones.
Remme WJ
Eur Heart J; 1998 Sep; 19 Suppl J():J16-23. PubMed ID: 9796836
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin system as a target for therapeutic intervention.
Swales JD
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
[TBL] [Abstract][Full Text] [Related]
15. [Converting enzyme inhibitors and coronary failure].
Castaigne A; Saal JP; Albo C; Verschuren P; Pham I
Rev Prat; 1992 Dec; 42(20):2568-73. PubMed ID: 1299942
[TBL] [Abstract][Full Text] [Related]
16. Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.
Banerjee A; Talreja A; Sonnenblick EH; LeJemtel TH
Mt Sinai J Med; 2003 Sep; 70(4):225-31. PubMed ID: 12968195
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
Epstein BJ; Gums JG
Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
[TBL] [Abstract][Full Text] [Related]
18. Blocking the renin-angiotensin system: dual- versus mono-therapy.
Ravandi A; Teo KK
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
[TBL] [Abstract][Full Text] [Related]
19. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
[TBL] [Abstract][Full Text] [Related]
20. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
Lévy S
Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
